7 day study of the safety, efficacy and the pharmacokinetic and pharmacodyamic properties of oral rivaroxaban in children from birth to less than 6 months with catheter-related aterial or venous thrombosis
Clinical Trial Grant
Administered By
Pediatrics, Critical Care Medicine
Awarded By
Bayer Healthcare Pharmaceuticals Inc
Start Date
October 12, 2015
End Date
September 10, 2018
Administered By
Pediatrics, Critical Care Medicine
Awarded By
Bayer Healthcare Pharmaceuticals Inc
Start Date
October 12, 2015
End Date
September 10, 2018